Monte Rosa Therapeutics (NASDAQ: GLUE)
$4.83
(3.4%)
$0.16
Price as of August 28, 2025, 4:00 p.m. ET
Monte Rosa Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Monte Rosa Therapeutics Company Info
Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.